JNJ Vaccine Trial: Disappointing Results

The news this morning from Johnson & Johnson (NYSE: JNJ) on the one-shot JNJ vaccine was very disappointing. Johnson & Johnson said the JNJ vaccine had an overall 66%… Read more

Inside the GameStop Trading Conspiracy

Shares of GameStop (NYSE: GME) are up 1,720% in 2021. That’s costing some Wall Street hedge funds billions in losses. And it’s making these “smart guys” very, very upset…. Read more

Inside WallStreetBets and 1,914% Gains for GameStop

Millions of online traders are out for blood. They’re on a mission to destroy hedge funds that “short sell” stocks, manipulate the markets and rob individual investors. David versus… Read more

JNJ Vaccine: 100 Million Doses Coming to U.S.

Vaccines like the JNJ vaccine will eventually give us our lives back. But for now, they do not signal the end of the pandemic. Not yet. The latest research… Read more

Microsoft Gets Big Boost From the Pandemic

A looming syringe shortage has health officials concerned. The world’s largest syringe maker, Becton Dickinson (NYSE: BDX), does not have the capacity to substantially increase U.S. supplies of specialty… Read more

JP Morgan Reveals New EV Buy List

 “EV Stocks are on Fire,” according to Barron’s magazine. Yet Wall Street is RESTRICTED from recommending new IPOs for 40 days. That means these stocks could soar after getting… Read more

WSJ: Profit from the EV Battery Boom of 2021

Joe Biden is sparking a new EV boom. The new president plans to replace American government-owned vehicles with new electric vehicles The move could spark huge demand for new… Read more

Why Merck Quit Its Covid Vaccines

The spread of the virus variants in the U.S. seems to grow every day. Yesterday, Minnesota’s health department said it had detected a virus variant found in Brazil. It… Read more

Moderna Testing New Vaccine Booster Shot

The Moderna vaccine may be less effective against the South African Covid-19 variant . . . one of the variants that has scientists so concerned. That is why Moderna… Read more

To top